quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:07·56d
SECFiling
RxSight Inc. logo

SEC Form EFFECT filed by RxSight Inc.

RXST· RxSight Inc.
Health Care
Original source

Companies

  • RXST
    RxSight Inc.
    Health Care

Recent analyst ratings

  • Jan 30UpdateWilliam Blair-
  • Jul 15UpdateMorgan Stanley$9.00
  • Jul 10UpdateJefferies$9.00
  • Jul 9UpdateOppenheimer-
  • Jul 9UpdateWells Fargo$9.00
  • Jul 9UpdateBTIG Research-

Related

  • PR1d
    RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
  • INSIDER3d
    SEC Form 4 filed by Goldshleger Ilya
  • PR15d
    RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026
  • PR21d
    RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by RxSight Inc.
  • SEC35d
    Amendment: SEC Form 8-K/A filed by RxSight Inc.
  • INSIDER51d
    Chief Financial Officer Wilterding Mark converted options into 20,441 shares and covered exercise/tax liability with 8,068 shares (SEC Form 4)
  • INSIDER51d
    Chief Customer Officer Gaines Scott converted options into 6,261 shares and covered exercise/tax liability with 2,580 shares, increasing direct ownership by 33% to 14,848 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022